Alexion Pharma Canada
Alexion is focused on providing innovative treatments to patients with severe and life-threatening rare diseases for which there are few, if any, effective treatment options. In 2009, Alexion began operations in Canada to serve patients locally. We aim to work in partnership with all stakeholders including healthcare providers, patient advocacy organizations and government in order to best serve patients. By expanding the knowledge and awareness of rare diseases, we help the medical community improve the process for diagnosis and treatment. Our goal is to bring hope to patients and families by delivering life-changing therapies.
In Canada, Soliris® has received marketing authorization from Health Canada for all patients with PNH. Soliris® is also approved by Health Canada as safe and effective for use in children and adults with atypical HUS to inhibit complement-mediated thrombotic microangiopathy (TMA). To further advance the understanding of PNH and atypical HUS in the Canadian population, Alexion Canada sponsors disease registries that enroll treated and untreated patients who are diagnosed with these conditions. This is our commitment to ongoing research into the rare conditions that our therapies treat.
Learn more about Alexion’s research and development efforts.
Innovative Medicines Canada
Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop, and deliver innovative medicines and vaccines. Our membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system. We aim to achieve these goals by forming effective alliances and supporting policies, improving Canada’s regulatory environment, widen access to innovative medicines and protect intellectual property. We believe in ensuring that Canadians have access to the innovative treatments they need and that our activities are a fundamental part of safeguarding our healthcare system for future generations. Our work allows our members to focus on what matters: delivering better healthcare solutions to Canadians.
Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. This site is intended for residents of the United States and its territories.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi entities in Canada employ approximately 1,900 people. In 2017 we invested over $123 million in R&D in Canada, creating jobs, business and opportunity throughout the country. Sanofi, Empowering Life.
Shift Health brings a science mindset to strategy consulting for the health research and innovation ecosystem. We blend scientific depth, sector leadership and global perspective, tackling our clients’ most challenging questions with curiosity, rigour and courage. Delivering sharp insights and customized solutions, we’re helping to create the future of healthcare.
Silicon Valley Bank
More than 35 years ago, Silicon Valley Bank was born into the heart of the innovation economy. We’ve believed in and worked with some of the world’s greatest innovators and their investors, helping to move their bold ideas forward, fast.
Our unique financial solutions, insights and connections have been helping Canadian technology and life science businesses and their investors to succeed. We understand how unpredictable development timelines, regulations and reimbursement cycles can stand in the way of innovation and growth. We provide financial services to help you hit your milestones.
In 2019 we opened an office in Toronto dedicated to lending to Canadian businesses and their investors.
AdMare BioInnovation is a global life sciences venture powering the industry by creating and growing companies of scale- while training the scientific and business talent needed to drive them to become leading global anchors here in Canada.
We build collaborations with the very best partners from academia, industry, patient foundations, the investment community, and other Key Opinion Leaders to provide the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector – and ultimately into new therapies for patients.
ANTIBODY Healthcare Communications
ANTIBODY’s doors opened with a bang in 2003, in a collaborative effort by ex-pharmaceutical marketer James Cran and the late great creative director Michael Paul, to re-invent the healthcare communications agency. James and Michael would build the first agency focused on being a true strategic partner. An agency that takes ownership of a brand the way you do. An agency that “gets it”. ANTIBODY is one of Canada’s premier full-service healthcare marketing agencies. With offices in Toronto and Montreal, we offer a complete range of strategic services. You name it we do it! We provide true client partnerships with a staff that is focused on one goal, results. Over the years ANTIBODY has developed a unique process that distills complex issues down to simple strategies and strong selling messages. Quickly. Too much perplexing marketing-speak coming from your agency? Time to simplify. We pride ourselves on delivering a significant impact on sales through unmatched marketing and creative thinking, simplification of the process and overall superior service.
Horizon Therapeutics Canada
Horizon Therapeutics Canada is a wholly owned subsidiary of Horizon Pharma plc, a biopharmaceutical company focused on improving patients’ lives by developing and commercializing differentiated and accessible medicines that address unmet medical needs in the fields of rare diseases, rheumatology and primary care. Founded in 2008 as a small start-up, Horizon has evolved in less than a decade into a global biopharmaceutical company active in several important therapeutic fields.
Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Taiho Pharma Canada Inc.
Taiho Pharma Canada, Inc., a Canadian subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), is located in Oakville, Ontario and managed by Taiho Oncology based in Princeton, New Jersey. Taiho Pharma’s mission in Canada is to lead oncology innovation, drive research and transform the lives of Canadians living with cancer. Taiho Oncology has established world class clinical development and commercial organizations that work urgently to develop and market innovative cancer treatments. Taiho Oncology Inc. has an oral oncology pipeline consisting of both novel anti-metabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the art facilities are helping Taiho define the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.
BDO Canada has spent more than 90 years providing assurance, accounting, tax, and advisory services to a broad range of clients across the country. And as a member firm of the international BDO network, we leverage access to resources and advisors in more than 150 countries around the world.
Founded in 1921, we have grown from a single office in Winnipeg to more than 3,000 partners and professionals in over 100 offices across Canada. Yet our strengths remain firmly rooted in the communities we serve.
At BDO, we aim to create a collaborative working environment that makes it possible for our professionals and clients to achieve their goals. We always begin at the local, individual level, delivering highly personalized guidance, industry-specific knowledge, and unparalleled service to exceed the expectations of every client – public or private, big or small. And as our team and our clients’ needs expand globally, we draw on our resources around the world.
CRB is solely focused on life sciences and advanced technology facilities with a community of multi-disciplinary experts that have dedicated their professional lives to this market. Our process-first design methodology creates an efficient, customized solution from consulting to construction. We call it ONEsolution™.
Ernst & Young LLP
At EY, we are committed to building a better working world — with increased trust and confidence in business, sustainable growth, development of talent in all its forms, and greater collaboration. We want to build a better working world through our own actions and by engaging with like-minded organizations and individuals. This is our purpose — and why we exist as an organization. Running through our organization is a strong sense of obligation to serve a number of different stakeholders who count on us to deliver quality and excellence in everything we do. We want to use our global reach and scale to convene the conversation about the challenges facing economies and the capital markets. When business works better, the world works better. Learn more about our commitment to building a better working world.
Doing now what patients need next.
We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.
That is why we come to work each day. We commit ourselves to scientific rigour, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.
We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world.
We are Roche.
University of Toronto Arts & Science Co-op
Simplify your recruiting process by partnering with the University of Toronto Arts & Science Co-op program. We offer the unique option of 4, 8 or 12-month work terms, allowing you to choose the duration that best suits your organization’s projects and needs. Students are available year-round from 35 programs including our top-ranked Biochemistry, Chemistry, Molecular Biology and Biotechnology, Neuroscience and Computer Science programs.
Our recruiting process is simple: recruit according to your timelines and make offers to your chosen candidate – we’ll handle the rest. From posting to hiring, we can help you find a great fit in as few as 10 days.